Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: A magnetic resonance imaging study

Archives of General Psychiatry

Volumn 59, Issue 4, 2002, Pages 332-336

  McCreadie, Robin G ^a   Thara, Rangaswamy ^b   Padmavati, Ramachandran ^b   Srinivasan, Tirupati N ^b   Jaipurkar, Sandeep D ^c  

^a Crichton Royal Hospital   (United Kingdom)

^b SCHIZOPHRENIA RESEARCH FOUNDATION   (India)

^c VHS Medical Centre India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DYSKINESIA; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; RATING SCALE; SCHIZOPHRENIA; STRUCTURE ANALYSIS;

EID: 0036218917     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.4.332     Document Type: Article

References (33)

1. Abnormal movements in never-medicated Indian patients with schizophrenia
2. Poor memory, negative symptoms and abnormal movements in never-treated Indian patients with schizophrenia
3. Computerized tomography in patients with tardive dyskinesia
4. Evaluation of CT scans in tardive dyskinesia
5. Computerized tomography in tardive dyskinesia: Evidence of structural abnormalities in the basal ganglia system
6. Tardive dyskinesia: Clinical correlation with computed tomography in patients aged less than 60 years
7. CT abnormalities in tardive dyskinesia
8. Computed tomographic evaluation of patients with tardive dyskinesia
9. MRI abnormalities in tardive dyskinesia
10. MRI in schizophrenia: Basal ganglia and white matter T1 times
11. Brain atrophy and intellectual impairment in tardive dyskinesia
12. Basal ganglia pathology in schizophrenia and tardive dyskinesia: An MRI quantitative study
13. Basal ganglia abnormalities in tardive dyskinesia: Possible relationship with duration of neuroleptic treatment
14. Caudate nucleus morphology in tardive dyskinesia
15. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs
16. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task
17. Decreased caudate volume in neuroleptic-naive psychotic patients
18. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia
19. Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network
20. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
21. Abnormal Involuntary Movements Scale (AIMS)
22. A rating scale for extrapyramidal side effects
23. Research diagnoses for tardive dyskinesia
24. Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia
25. Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study
26. Changes in caudate volume with neuroleptic treatment
27. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: Preliminary findings
28. Methods for measuring brain morphologic features on magnetic resonance images: Validation and normal aging
29. Cerebral structure on MRI. I: Localization of age-related changes
30. Ventricular enlargement in schizophrenia evaluated with computed tomographic scanning: Effects of gender, age, and stage of illness
31. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients
32. Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients